Clinical trial · Observational
The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
NCT06245759CI-TRIAL-00073710unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Based on large sample size studies at home and abroad, the prognosis of patients with non-muscular invasive bladder cancer in different sites undergoing transurethral bladder tumor resection was determined, providing important guidance for subsequent clinical treatment and surgical instrument development.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
| Non-Muscle-Invasive Bladder Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| This was a retrospective study and no patient intervention was performed | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- the U.S. National Cancer Center SEER database
- description
- The Chinese NMIBC cohort includes patients from January 1996 to December 2019 at 15 institutions.
- interventionNames
- Other: This was a retrospective study and no patient intervention was performed
- label
- the Chinese Bladder Cancer Alliance CBCC database
- description
- SEER\*Stat software (version 8.4.1.1) collected 17 registries cohort data on NMIBC patients diagnosed between 2000 and 2020.
- interventionNames
- Other: This was a retrospective study and no patient intervention was performed
Primary outcomes (2)
- measure
- Overall survival time
- timeFrame
- up to 20 years
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Initially diagnosed with non-muscular invasive bladder cancer (NMIBC) who underwent TURBT or partial cystectomy. 2. The follow-up data of the patients were complete. 3. The tumor location information were complete. Exclusion Criteria: 1. Patients with unknown survival time or missing tumor location information were excluded. 2. Exclude patients with missing pathological results. 3. Exclude patients who have had TURBT before.
References
Publications (1)
- DERIVEDLiu L, Li K, Wang SG, Wang J, Yao Z, Xie Y, Ji Z, Chen Z, Hu H, Chen H, Hu J, Hou Y, Liu Z, Li Y, Ding Y, Kuang Y, Xun Y, Hu J, Zhang J, Li H, Chong T, Bi J, Wang Z, Wang Y, Zhang P, Wei Q, Chen Z, Li L, Huang J, Liu Z, Chen K; Chinese Bladder Cancer Consortium. The prognostic impact of tumor location in nonmuscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing Chinese multicenter and SEER registries. Int J Surg. 2024 Sep 1;110(9):5641-5651. doi: 10.1097/JS9.0000000000001675. PMID 38788195